Get the Stockscreener App
1.12
1.33%
-0.010
Waldencast Plc stock is traded at $1.12, with a volume of 47,998.
It is down -1.33% in the last 24 hours and down -35.17% over the past month.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
See More
Previous Close:
$1.13
Open:
$1.16
24h Volume:
47,998
Relative Volume:
0.67
Market Cap:
$143.01M
Revenue:
$272.07M
Net Income/Loss:
$-248.06M
P/E Ratio:
-0.5554
EPS:
-2.0167
Net Cash Flow:
$-16.48M
1W Performance:
-23.10%
1M Performance:
-35.17%
6M Performance:
-44.53%
1Y Performance:
-63.44%
1-Day Range:
$1.095
$1.19
1-Week Range:
$1.095
$1.435
52-Week Range:
$1.095
$3.22
Waldencast Plc Stock (WALD) Company Profile
Name
Waldencast Plc
Sector
Industry
Phone
(917) 546-6828
Address
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.115 | 144.93M | 272.07M | -248.06M | -16.48M | -2.0167 |
PG
Procter Gamble Co
|
143.90 | 332.70B | 85.26B | 16.53B | 14.85B | 6.7488 |
UL
Unilever Plc Adr
|
60.66 | 132.45B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
85.31 | 67.75B | 20.38B | 2.26B | 3.63B | 2.6214 |
KVUE
Kenvue Inc
|
17.56 | 33.64B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
99.08 | 32.83B | 17.23B | 1.75B | 1.64B | 6.0654 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-26 | Resumed | Jefferies | Buy |
| Nov-25-25 | Downgrade | Telsey Advisory Group | Outperform → Market Perform |
| Apr-22-25 | Initiated | Alliance Global Partners | Buy |
| Dec-16-24 | Initiated | TD Cowen | Hold |
| Oct-25-24 | Initiated | Canaccord Genuity | Buy |
| May-01-24 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Waldencast Plc Stock (WALD) Latest News
This $175 serum says it can make skin look up to 6 years younger - Stock Titan
Aug Technicals: Can Waldencast plc Equity Warrant outperform in the next rally2026 Highlights & Long-Term Capital Growth Strategies - baoquankhu1.vn
Waldencast (WALD) Oppenheimer's 24th Annual Consumer Growth and E-Commerce Conference summary - Quartr
17 ProMD clinics across states will evaluate Obagi's MagIQ - Stock Titan
Waldencast plc (WALD) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Waldencast (WALD) CEO Michel Brousset reports options, RSUs and indirect stakes - Stock Titan
Waldencast (WALD) director details large indirect share, warrant and option holdings - Stock Titan
Waldencast plc (WALD) director reports direct and indirect share stakes - Stock Titan
[Form 3] Waldencast plc Initial Statement of Beneficial Ownership - Stock Titan
Waldencast (WALD) director lists 37,454 Class A Ordinary Shares - Stock Titan
Waldencast (WALD) director details initial share and RSU holdings - Stock Titan
Waldencast (WALD) director Felipe Dutra files initial Form 3 ownership report - Stock Titan
[Form 3] Waldencast plc Initial Stateme... - Stock Titan
Waldencast (WALD) executive Hind Sebti details options, RSUs and shares - Stock Titan
Canaccord cuts Waldencast stock price target on elevated costs By Investing.com - Investing.com South Africa
Canaccord cuts Waldencast stock price target on elevated costs - Investing.com
Analysts Offer Insights on Consumer Goods Companies: American Public Education (APEI) and Waldencast (WALD) - The Globe and Mail
Waldencast (WALD) Trailing US$229.7 Million Loss Reinforces Bearish Profitability Narratives - Sahm
Waldencast Acquisition earnings missed by $0.18, revenue fell short of estimates - Investing.com UK
Waldencast plc Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Waldencast Q4 2025 Earnings: Revenue Flat at $72M as Brand Transformation Takes Shape - technotrenz.com
Waldencast Q4 Financial Results Analysis - Intellectia AI
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive - TipRanks
Waldencast Reports Q4 2025 and FY 2025 Financial Results - The Manila Times
Waldencast Reports Flat FY 2025 Revenue of $272.1 Million, Highlights Strategic Advancements in Beauty and Wellness Brands - Quiver Quantitative
CORRECTED-BRIEF-Waldencast plc. Q4 Adjusted EBITDA USD 6.6 Million - TradingView
WALDWaldencast plc Latest Stock News & Market Updates - Stock Titan
Waldencast (NASDAQ: WALD) posts larger 2025 loss as EBITDA drops - Stock Titan
Big impairments and control risks at Waldencast (Nasdaq: WALD) in 2025 filing - Stock Titan
Quarterly Risk: Will Waldencast plc stock benefit from M A2026 Dividend Review & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Waldencast (WALD) Projected to Post Quarterly Earnings on Thursday - Defense World
Waldencast plc to Release Fourth Quarter and Fiscal Year 2025 Earnings Report on March 11, 2026 - geneonline.com
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date - Bitget
Price Action: Can Waldencast plc disrupt its industryJuly 2025 Review & Free High Return Stock Watch Alerts - baoquankhu1.vn
Quarterly Trades: Can Waldencast plc Equity Warrant navigate macro headwindsJuly 2025 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
WALD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WALD Should I Buy - Intellectia AI
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Schweiger clinics to trial new Obagi injectable in real-world ALOHA program - Stock Titan
New Highs: Is Waldencast plc Equity Warrant stock a value trapEarnings Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Guidance Update: Can Waldencast plc Equity Warrant outperform in the next rallyFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Obagi Medical and It's a Secret Med Spa announce collaboration in the Aloha program - marketscreener.com
Obagi Medical and It’s a Secret Med Spa Announce - GlobeNewswire
Luxury med spa chain to evaluate Obagi’s new ALOHA hyaluronic injectable - Stock Titan
Does Waldencast plc Equity Warrant have a sustainable dividendIPO Watch & Weekly Return Optimization Alerts - mfd.ru
Will Waldencast plc Equity Warrant face regulatory challengesMarket Sentiment Summary & Weekly Breakout Stock Alerts - mfd.ru
How The Waldencast (WALD) Narrative Is Shifting As Outlook Resets Meet Brand Optimism - Yahoo Finance
Earnings Report: Can Waldencast plc Equity Warrant navigate macro headwindsLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels - MSN
Waldencast outlines mid-teens revenue growth for 2025 backed by brand expansion - MSN
Downgrade Watch: Can Waldencast plc Equity Warrant outperform in the next rallyTrade Signal Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Waldencast Plc Stock (WALD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):